Federation des caisses Desjardins du Quebec’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Federation des caisses Desjardins du Quebec's HZNP Position: Q4 2023 in Review
Federation des caisses Desjardins du Quebec sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 792 shares — an estimated $91.6K sold.
Federation des caisses Desjardins du Quebec first reported a position in HZNP in Q1 2017 and held it in 17 quarters. The position peaked at $1.34M in Q1 2017. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Federation des caisses Desjardins du Quebec reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Federation des caisses Desjardins du Quebec sold 792 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $91.6K.
- Federation des caisses Desjardins du Quebec first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 17 quarters.
- Federation des caisses Desjardins du Quebec's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.34M in Q1 2017.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2023, filed 15 Aug 2024.